共 50 条
The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis
被引:23
|作者:
Janmohamed, Sherief R.
[1
]
Gwillim, Eran C.
[2
]
Yousaf, Muhammad
[2
]
Patel, Kevin R.
[3
]
Silverberg, Jonathan I.
[4
]
机构:
[1] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel UZB, Dept Dermatol, Laarbeeklaan 101, B-1090 Jette, Belgium
[2] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] George Washington Univ, Sch Med, Dept Dermatol, 2150 Penn Ave,Suite 2B-430, Washington, DC 20037 USA
关键词:
Besnier;
Chronic itch;
DLQI;
EQ5D;
Hyde’
s prurigo;
Itch;
IchyQoL;
Meta-analysis;
Nodular prurigo;
NRS;
Prurigo;
Prurigo nodularis;
Pruritis;
Pruritus;
QoL;
Quality of life;
Systematic review;
VAS;
VRS;
INTERNATIONAL FORUM;
EUROPEAN ACADEMY;
DERMATOLOGY;
ITCH;
CLASSIFICATION;
CONSENSUS;
SEVERITY;
D O I:
10.1007/s00403-020-02148-0
中图分类号:
R75 [皮肤病学与性病学];
学科分类号:
100206 ;
摘要:
Prurigo nodularis (PN) is a chronic, pruritic, debilitating disease. Previous studies found that chronic pruritus in general negatively affects patients' quality of life (QoL). However, results about the impact of PN on QoL are conflicting. Our objective was to assess the QoL burden of PN. A systematic review was conducted of all published studies that assessed QoL measures in PN. OVID MEDLINE, EMBASE, SCOPUS, and Web of Science were searched. Pooled meta-analysis (means) was performed using random-effects weighting. Overall, 13 studies met inclusion criteria. All studies identified QoL reductions in patients suffering from PN compared to control groups. The most common QoL instrument used was the Dermatology Life Quality Index [n = 9 studies; pooled mean (95% confidence interval): 13.8 (10.6-16.9), denoting a very large effect]. In particular, PN was associated with substantial impact on multiple domains of QoL. No publication bias was detected. In conclusion, QoL is negatively impacted in PN. Future studies are necessary to determine the best instruments of measuring QoL in PN patients, better understand this association, and assess the impact in males and females separately. PROSPERO CRD42019136193.
引用
收藏
页码:669 / 677
页数:9
相关论文